Dr. Farhat Afrin
Associate ProfessorCentre for Interdisciplinary Sciences, JISIASR (Year of joining 2022)Post-Doc (2010): Centre for Immunology and Infection, The Hull York Medical School, University of York, U.K.Post-Doc (2002-03): NIAID, National Institutes of Health, Bethesda, MD, USAPh.D. (1994-1999): Jadavpur University, Kolkata, West BengalM.Sc. (1991-1993): Biotechnology, Aligarh Muslim University, U.P.Email: afrin@jisiasr.orgResearcher ID (Web of Science): F-2346-2018Author ID (Scopus): 6602621730ORCID ID: 0000-0003-4443-4284Loop profile: 119563URLs:https://vidwan.inflibnet.ac.in/profile/278778https://jisiasr.org/dr-farhat-afrin/https://orcid.org/0000-0003-4443-4284https://www.scopus.com/authid/detail.uri?authorId=6602621730https://scholar.google.com/citations?user=SwSWeiYAAAAJ&hl=en&oi=aohttps://www.linkedin.com/in/farhat-afrin-2b345870/https://www.researchgate.net/profile/Farhat-Afrin Professional Engagements:2022- Till Date: Associate Professor, Centre for Interdisciplinary Sciences,JISIASR, Kolkata, JIS University, West Bengal2014-2019: Assistant Professor, Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Taibah University, Madina, Saudi Arabia2006-2014: Assistant Professor, Department of Biotechnology, Jamia Hamdard (Hamdard University), New Delhi, India2003-2005: Lecturer (Sr. scale), Department of Biotechnology, Hamdard University, New Delhi, India 1999-2003: Lecturer, Department of Biotechnology, Hamdard University, New Delhi, India 1998-1999: Lecturer (Adhoc), Department of Biotechnology, Hamdard University, New Delhi, India Research Areas of Specialization:Main Area: Biotechnology/ Molecular Medicine; Sub-area: Immunology/ Nanomedicine/Herbal Medicine/ EpigeneticsArea (Specialization):Our research encompasses vaccinology, immune-therapeutics, herbal- and nanomedicine and epigenetic changes in infectious diseases. We are currently investigating therapeutic interventions of infectious diseases, leishmaniasis and cancer using herbal medicines and nanoparticles alone or as drug carriers.Prophylactic and therapeutic nano-vaccines against leishmaniasis and other infectious diseasesis also being explored.Epigenetic modifications during disease pathogenesis and treatment are also being studied. Academic ExpertiseTeaching Experience (post-Ph.D.) :24 years (1999 – Till Date)Research Experience :29 years (1994 – Till Date);post-Ph.D. – 24 years (1999 – Till Date) PublicationsBook Chapters published and role : 3 (As Corresponding author)Books published and role : 2 (As Editor); 1 (As Co-Editor)Research papers published and role : 64 (Web of Science), 61 (Scopus)Total citations : 2188 (Web of Science), 2502 (Scopus)h-index : 29 (Web of Science), 33 (Scopus)Cumulative impact factor : 229 Research GuidanceNumber of Ph.D. students supervised and role: 4 (As Supervisor); 11 (As Co-Supervisor)Number of Masters (Biotechnology) students supervised and role: 61 (As Supervisor)Number of Bachelors (Medical Laboratory Technology) students supervised and role: 9 (As Supervisor) Research Grants /Projects Awarded/Completed (with role and budget amount): Four as Principal Investigator (Rs. 146.628 Lakhs); One as Co-Investigator (Rs. 37.98696 Lakhs)Editorial Board Member of Peer Reviewed International Journals/ Books: 23Reviewer of International Journals: 62Research Paper Presentations/ Chairing Session in Conference/Keynote Speaker: 39Abstracts from Proceedings of Seminars/Symposia/Workshops: 98Collaborations with Research Institutes/ Universities:11Life Membership in Professional Societies: 3
